Kevin Duffy

Kevin Duffy has worked in the pharmaceutical industry since 2006. Kevin started their career at Takeda Pharmaceuticals (formerly Nycomed) as a Laboratory Head and Research Scientist (DMPK). In 2009 they moved to Roche Pharmaceuticals as a Clinical Pharmacology Scientist (pRED) - Basel. Kevin then joined DS Biopharma in 2012 as Director of Translational Medicine and Clinical Research Executive. In 2014, they were a Senior Clinical Science Manager and Clinical Science Manager at ONO PHARMACEUTICAL CO., LTD. In 2018, they moved to Roche as a Senior Clinical Scientist (Oncology) - Development. Since 2019, they have been a Clinical Scientist, Director at Autolus Ltd. and in 2022 they will become a Clinical Scientist, Director at Crescendo Biologics Limited.

Kevin Duffy received their PhD in Pharmacology and Drug Transport from the University of Aberdeen in 2006. Prior to that, they earned a BSc. (Hons) in Physiology from University College Cork in 2002.